Cargando…
Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin
To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448924/ https://www.ncbi.nlm.nih.gov/pubmed/26045659 http://dx.doi.org/10.2147/DDDT.S80948 |
_version_ | 1782373790040195072 |
---|---|
author | Liu, Ran Wang, Yonglu Li, Xueming Bao, Wen Xia, Guohua Chen, Wei Cheng, Jian Xu, Yuanlong Guo, Liting Chen, Baoan |
author_facet | Liu, Ran Wang, Yonglu Li, Xueming Bao, Wen Xia, Guohua Chen, Wei Cheng, Jian Xu, Yuanlong Guo, Liting Chen, Baoan |
author_sort | Liu, Ran |
collection | PubMed |
description | To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet–PLGA–PLL–PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet–PLGA–PLL–PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA–PLL–PEG–Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet–PLGA–PLL–PEG–Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet–PLGA–PLL–PEG–Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet–PLGA–PLL–PEG–Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet–PLGA–PLL–PEG-NPs. These results clearly indicate that the PLGA–PLL–PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties. |
format | Online Article Text |
id | pubmed-4448924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44489242015-06-04 Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin Liu, Ran Wang, Yonglu Li, Xueming Bao, Wen Xia, Guohua Chen, Wei Cheng, Jian Xu, Yuanlong Guo, Liting Chen, Baoan Drug Des Devel Ther Original Research To increase the encapsulation of hydrophilic antitumor agent daunorubicin (DNR) and multidrug resistance reversal agent tetrandrine (Tet) in the drug delivery system of nano-particles (NPs), a functional copolymer NP composed of poly(lactic-co-glycolic acid) (PLGA), poly-L-lysine (PLL), and polyethylene glycol (PEG) was synthesized and then loaded with DNR and Tet simultaneously to construct DNR/Tet–PLGA–PLL–PEG-NPs using a modified double-emulsion solvent evaporation/diffusion method. And to increase the targeted antitumor effect, DNR/Tet–PLGA–PLL–PEG-NPs were further modified with transferrin (Tf) due to its specific binding to Tf receptors (TfR), which is highly expressed on the surface of tumor cells. In this study, the influence of the diversity of formulation parameters was investigated systematically, such as drug loading, mean particle size, molecular weight, the concentration of PLGA–PLL–PEG–Tf, volume ratio of acetone to dichloromethane, the concentration of polyvinyl alcohol (PVA) in the external aqueous phase, the volume ratio of the internal aqueous phase to the external aqueous phase, and the type of surfactants in the internal aqueous phase. Meanwhile, its possible effect on cell viability was evaluated. Our results showed that the regular spherical DNR/Tet–PLGA–PLL–PEG–Tf-NPs with a smooth surface, a relatively low polydispersity index, and a diameter of 213.0±12.0 nm could be produced. The encapsulation efficiency was 70.23%±1.91% for DNR and 86.5%±0.70% for Tet, the moderate drug loading was 3.63%±0.15% for DNR and 4.27%±0.13% for Tet. Notably, the accumulated release of DNR and Tet could be sustained over 1 week, and the Tf content was 2.18%±0.04%. In cell viability tests, DNR/Tet–PLGA–PLL–PEG–Tf-NPs could inhibit the proliferation of K562/ADR cells in a dose-dependent manner, and the half maximal inhibitory concentration value (total drug) of DNR/Tet–PLGA–PLL–PEG–Tf-NPs was lower than that of DNR, a mixture of DNR and Tet, and DNR/Tet–PLGA–PLL–PEG-NPs. These results clearly indicate that the PLGA–PLL–PEG formulation is a potential drug delivery system for hydrophilic and hydrophobic drugs, and that Tf modification may increase its targeting properties. Dove Medical Press 2015-05-22 /pmc/articles/PMC4448924/ /pubmed/26045659 http://dx.doi.org/10.2147/DDDT.S80948 Text en © 2015 Liu et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Liu, Ran Wang, Yonglu Li, Xueming Bao, Wen Xia, Guohua Chen, Wei Cheng, Jian Xu, Yuanlong Guo, Liting Chen, Baoan Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title | Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title_full | Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title_fullStr | Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title_full_unstemmed | Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title_short | Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
title_sort | synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448924/ https://www.ncbi.nlm.nih.gov/pubmed/26045659 http://dx.doi.org/10.2147/DDDT.S80948 |
work_keys_str_mv | AT liuran synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT wangyonglu synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT lixueming synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT baowen synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT xiaguohua synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT chenwei synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT chengjian synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT xuyuanlong synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT guoliting synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin AT chenbaoan synthesisandcharacterizationoftumortargetedcopolymernanocarriermodifiedbytransferrin |